FRANCE’S Pasteur Institute said today it was ending development of a Covid-19 vaccine with US pharmaceutical company Merck after clinical trial results proved disappointing.
The partners announced a tie-up last May to develop a jab based on an existing measles vaccine, which was put into Phase 1 clinical trials in August.